These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26967714)

  • 1. Comparison of newly developed anti-bone morphogenetic protein 4 llama-derived antibodies with commercially available BMP4 inhibitors.
    Calpe S; Correia AC; Sancho-Serra Mdel C; Krishnadath KK
    MAbs; 2016; 8(4):678-88. PubMed ID: 26967714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective Inhibition of Bone Morphogenetic Protein Function by Highly Specific Llama-Derived Antibodies.
    Calpe S; Wagner K; El Khattabi M; Rutten L; Zimberlin C; Dolk E; Verrips CT; Medema JP; Spits H; Krishnadath KK
    Mol Cancer Ther; 2015 Nov; 14(11):2527-40. PubMed ID: 26351325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of Clostridium difficile toxin-specific single-domain antibodies.
    Hussack G; Arbabi-Ghahroudi M; Mackenzie CR; Tanha J
    Methods Mol Biol; 2012; 911():211-39. PubMed ID: 22886255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Camelid single-domain antibodies raised by DNA immunization are potent inhibitors of EGFR signaling.
    Rossotti MA; Henry KA; van Faassen H; Tanha J; Callaghan D; Hussack G; Arbabi-Ghahroudi M; MacKenzie CR
    Biochem J; 2019 Jan; 476(1):39-50. PubMed ID: 30455372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies.
    van der Linden RH; Frenken LG; de Geus B; Harmsen MM; Ruuls RC; Stok W; de Ron L; Wilson S; Davis P; Verrips CT
    Biochim Biophys Acta; 1999 Apr; 1431(1):37-46. PubMed ID: 10209277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models.
    Li S; Hoefnagel SJM; Read M; Meijer S; van Berge Henegouwen MI; Gisbertz SS; Bonora E; Liu DSH; Phillips WA; Calpe S; Correia ACP; Sancho-Serra MDC; Mattioli S; Krishnadath KK;
    Cell Oncol (Dordr); 2022 Aug; 45(4):639-658. PubMed ID: 35902550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly specific and potently activating Vγ9Vδ2-T cell specific nanobodies for diagnostic and therapeutic applications.
    de Bruin RCG; Lougheed SM; van der Kruk L; Stam AG; Hooijberg E; Roovers RC; van Bergen En Henegouwen PMP; Verheul HMW; de Gruijl TD; van der Vliet HJ
    Clin Immunol; 2016 Aug; 169():128-138. PubMed ID: 27373969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Legomedicine-A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody-Nanoparticle Conjugates.
    van Lith SA; van Duijnhoven SM; Navis AC; Leenders WP; Dolk E; Wennink JW; van Nostrum CF; van Hest JC
    Bioconjug Chem; 2017 Feb; 28(2):539-548. PubMed ID: 28045502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VHH antibodies: emerging reagents for the analysis of environmental chemicals.
    Bever CS; Dong JX; Vasylieva N; Barnych B; Cui Y; Xu ZL; Hammock BD; Gee SJ
    Anal Bioanal Chem; 2016 Sep; 408(22):5985-6002. PubMed ID: 27209591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Rational Engineering Strategy for Designing Protein A-Binding Camelid Single-Domain Antibodies.
    Henry KA; Sulea T; van Faassen H; Hussack G; Purisima EO; MacKenzie CR; Arbabi-Ghahroudi M
    PLoS One; 2016; 11(9):e0163113. PubMed ID: 27631624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of antigen-specific alpaca (Lama pacos) VHH antibodies by biopanning followed by high-throughput sequencing.
    Miyazaki N; Kiyose N; Akazawa Y; Takashima M; Hagihara Y; Inoue N; Matsuda T; Ogawa R; Inoue S; Ito Y
    J Biochem; 2015 Sep; 158(3):205-15. PubMed ID: 25888581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of TGF-β-neutralizing single-domain antibodies of predetermined epitope specificity using next-generation DNA sequencing.
    Henry KA; Hussack G; Collins C; Zwaagstra JC; Tanha J; MacKenzie CR
    Protein Eng Des Sel; 2016 Oct; 29(10):439-443. PubMed ID: 27613412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and Selection of 3-(1-Naphthoyl)-Indole Derivative-Specific Alpaca VHH Antibodies Using a Phage Display Library.
    Nakayama H; Murakami A; Yoshida M; Muraoka J; Wakai J; Kenjyou N; Ito Y
    Monoclon Antib Immunodiagn Immunother; 2016 Aug; 35(4):231-4. PubMed ID: 27556911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Llama VHH antibody fragments against GFAP: better diffusion in fixed tissues than classical monoclonal antibodies.
    Perruchini C; Pecorari F; Bourgeois JP; Duyckaerts C; Rougeon F; Lafaye P
    Acta Neuropathol; 2009 Nov; 118(5):685-95. PubMed ID: 19597828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Llama single domain antibodies as a tool for molecular mimicry.
    Zarebski LM; Urrutia M; Goldbaum FA
    J Mol Biol; 2005 Jun; 349(4):814-24. PubMed ID: 15890359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Camelid heavy chain only antibody fragment domain against β-site of amyloid precursor protein cleaving enzyme 1 inhibits β-secretase activity in vitro and in vivo.
    Dorresteijn B; Rotman M; Faber D; Schravesande R; Suidgeest E; van der Weerd L; van der Maarel SM; Verrips CT; El Khattabi M
    FEBS J; 2015 Sep; 282(18):3618-31. PubMed ID: 26147692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of llama single-domain antibodies against methotrexate, a prototypical hapten.
    Alvarez-Rueda N; Behar G; Ferré V; Pugnière M; Roquet F; Gastinel L; Jacquot C; Aubry J; Baty D; Barbet J; Birklé S
    Mol Immunol; 2007 Mar; 44(7):1680-90. PubMed ID: 17011035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insight in the inhibition of adherence of F4 fimbriae producing enterotoxigenic Escherichia coli by llama single domain antibodies.
    Moonens K; Van den Broeck I; Okello E; Pardon E; De Kerpel M; Remaut H; De Greve H
    Vet Res; 2015 Feb; 46():14. PubMed ID: 25828907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Camelid Single-Domain Antibodies for the Development of Potent Diagnosis Platforms.
    Brilhante-da-Silva N; de Oliveira Sousa RM; Arruda A; Dos Santos EL; Marinho ACM; Stabeli RG; Fernandes CFC; Pereira SDS
    Mol Diagn Ther; 2021 Jul; 25(4):439-456. PubMed ID: 34146333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lateral recognition of a dye hapten by a llama VHH domain.
    Spinelli S; Tegoni M; Frenken L; van Vliet C; Cambillau C
    J Mol Biol; 2001 Aug; 311(1):123-9. PubMed ID: 11469862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.